German Merck To Double Fund Size And Broaden Corporate VC Focus

Merck of Germany has decided to expand the activities of its corporate venture fund to include all aspects of its business rather than focusing on biopharma. Managing director of Merck Ventures Roel Bulthuis explains what led to the decision and why it won't affect Merck's commitment to innovation in healthcare, and may in fact boost productivity.